Illegal drugs manufacturing unit busted in Haridwar

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-06-09 11:05 GMT   |   Update On 2025-06-09 11:05 GMT

New Delhi: In a significant crackdown on illegal drug operations, the Narcotics Control Bureau (NCB) has uncovered an illicit drug-manufacturing unit in Uttarakhand’s Haridwar as a part of a six-month-long investigation that has led to the seizure of approximately 150 kilograms of narcotics and pharmaceutical tablets and the arrest of eight individuals.

The factory was operating in the SIIDCUL (State Infrastructure and Industrial Development Corporation of Uttarakhand Limited) area in Haridwar. Authorities discovered that the unit was functioning without a valid drug-manufacturing licence, PTI reported.

According to the NCB, the factory was engaged in the bulk production of psychotropic substances intended for illegal trafficking.

Read also: EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy

The operation, spread across Delhi, Uttar Pradesh and Uttarakhand, started with the interception of a courier containing 3.6 kg of codeine phosphate tablets in Delhi on January 9, NCB officials said.

Follow-up searches were conducted in Delhi and neighbouring Ghaziabad in Uttar Pradesh, leading to the seizure of tablets like 9.14 kg of alprazolam, 2.36 kg of codeine phosphate, about 10,000 multiple brand NRx tablets, 1.38 kg of psuedoephedrine and 130.44 kg of raw material in loose form, they added.
Eight people have so far been arrested as part of the investigation and more individuals are under the NCB's scanner, the officials said.
The NCB is committed to disrupting trans-national and interstate drug networks to achieve the vision of a drugs-free India, the statement said.
Medical Dialogues team had earlier reported that the NCB had arrested an MBBS doctor along with eight other individuals for their alleged involvement in a sophisticated smuggling network that spanned across five states, including Rajasthan, Madhya Pradesh, Tamil Nadu, Karnataka, and Maharashtra.
Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News